Piper Sandler Analysts Bullish on Allogene Therapeutics (ALLO) Ahead of Key ALPHA3 Data Readout

On: March 20, 2026, 3:16 pm EDT

URL has been copied successfully!

Share this story:

Previous Post:Analyst Sentiment Remains Strong on Iovance Biotherapeutics (IOVA) Amid U.S. Rollout of Melanoma Drug, Amtagvi

Next Post:Analysts Remain Bullish on MARA Holdings (MARA) Amid Company’s Strategic Transition to AI